Global Intellectual Property Center

Tag Archives: malaria

IP Delivers Access to Global Solutions

IP Delivers Access to Global Solutions

© YuriyS / iStock

Enter Dr. Stephen L. Hoffman, the CEO of the biotechnology company, Sanaria. Dr. Hoffman has spent nearly three decades of his professional career seeking what many other scientists had long given up on: a vaccine that protects people from contracting malaria. And Dr. Hoffman’s company is closer than ever. In a clinical trial at the NIH, Sanaria recently achieved 100% protection against malaria among a small sample of volunteers utilizing their PfSPZ Vaccine. Sanaria is developing the vaccine for two markets: The most important is the global health market, where the vaccine will first be used in mass administration campaigns to eliminate malaria in targeted populations.

Why the Race to Treat Malaria is More Like a Marathon

Why the Race to Treat Malaria is More Like a Marathon

© Kraivuttinun / iStock

Like finding the cure for cancer, this race to develop an antidote to malaria is more like a marathon. Health professionals have exhausted nearly 30 years of research and development and invested hundreds of millions of dollars to not just eradicate, but merely slow down the spread of malaria.

The Threat to Public Health Worse Than Obamacare

The Threat to Public Health Worse Than Obamacare

Image: ©iStockphoto.com / bonnie jacobs

Obamacare is bad enough. With burdensome regulations that strangle hiring, hurt small businesses, and disrupt healthcare, what more can we stand? Well, as it turns out, bad policies from overseas are also threatening to undo our healthcare system in an equally nefarious fashion.